Atom Computing
Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
$100MSeries C
Role not disclosedActivity from announced rounds
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
Builds utility-scale quantum computers using industry-standard silicon transistors
Develops GPS-enabled cattle collars using sensors, software and AI.